³Ô¹ÏÍøÕ¾

Latest pharmaceutical industry News

Data Sharing Is Patient Caring
Drug prices improved under Biden-Harris and Trump − but not for everyone, and not enough
Airdropping vaccines to eliminate canine rabies in Texas – two scientists explain the decades of research behind its success
Health care under Harris versus Trump: A public health historian sizes up their records
Why is it so hard to get drugs approved for use during pregnancy?
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
AusBiotech appoints senior leaders focused on advocacy, policy and elevating the voice of industry
Jackie Fairley Appointed To Baker Institute Board
Biden administration’s negotiated price cuts for 10 common prescription drugs likely to save Medicare billions, beginning in 2026
Dear Pharmac – do things differently: what David Seymour’s expectations could mean for the drug-buying agency
Further Transparency Needed In Cancer Clinical Trials
TeraPore uses Cornell research to address virus filtration challenges
A funding boost for NZ’s drug-buying agency Pharmac to pay for cancer drugs is welcome – but it won’t solve underlying issues
QUT’s seven new ARC Linkage projects focus on opportunities for Australia
Childhood cancer detectives embrace open-source AI solution
KnowBe4’s Annual Phishing Benchmarking Report Shows Focusing on the Human Element Still the Best Safeguard Against Cyber Threats
Why, for some, psychotherapy might be a better treatment for depression than drugs
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells
New health research hub to improve patient care and build health workforce in Victoria’s northern corridor
Drug companies pay doctors over A$11 million a year for travel and education. Here’s which specialties received the most
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
NACCHO 2024 Aboriginal and Torres Strait Islander Pharmacist Scholarship recipients announced
Industry applauds $18.8m funding for ³Ô¹ÏÍøÕ¾ One Stop Shop for clinical trials
We looked at genetic clues to depression in more than 14,000 people. What we found may surprise you
Setting new standards for healthcare: DB Schenker secures Good Distribution Practice (GDP) certification for more than 150 stations
IIdentification of Tropane Alkaloid Chemotypes and Genotypes in Hyoscyamus niger L
Ministerial Visit Focuses On Alzheimer’s Disease
LBT Innovations announces that its APAS PharmaQC product is commercially ready
Vaccine-skeptical mothers say bad health care experiences made them distrust the medical system
Acquisition Of Gracell Completed
Acquisition of Icosavax Completed
MinterEllison advises Arrotex on key health and beauty acquisitions
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data
Revealing the Landscape of Software as a Medical Device Industry
More than skin-deep
Antimicrobial Resistance: Silent Pandemic
New director for WEHI
With ACT and NZ First promising to overhaul Pharmac, what’s in store for publicly funded medicines?
New electronic WHO Prequalification System (ePQS) Portal set to launch by January 2024
US academic gains fresh perspective teaching in NZ
Eight essential leadership capabilities for 21st century
Engineering of plant cell wall modifying enzymes opens new horizons
Botanix Pharmaceuticals elevates chief operating officer to CEO position
New DNA drug to fight blood clots
Pills from 3D printer
Unemployment and underemployment significant drivers of suicide: analysis